<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=10082473" created="12/05/2006" creator="Yo Shidahara"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>10082473</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Molecular mechanisms of <term id="T2" lex="neutrophil-endothelial_cell_adhesion" sem="Other"><term id="A1" sem="Cell_natural">neutrophil</term>-<term id="A2" sem="Cell_natural">endothelial cell</term> adhesion</term> induced by <term id="T3" lex="redox_imbalance" sem="Other">redox imbalance</term>.</sentence>
<event KT="Other" id="E1">
<type class="Cell_adhesion"/>
<theme idref="A1"/>
<theme idref="A2"/>
<clue>Molecular mechanisms of neutrophil-endothelial cell <clueType>adhesion</clueType> induced by redox imbalance.</clue>
</event>
<event KT="Other" id="E2">
<type class="Positive_regulation"/>
<theme idref="E1"/>
<cause idref="T3"/>
<clue>Molecular mechanisms of neutrophil-endothelial cell adhesion <clueType>induced</clueType> <linkCause>by</linkCause> redox imbalance.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">Previous studies have implicated a role for <term id="T4" lex="intracellular_thiols" sem="Organic_compound_other">intracellular thiols</term> in the activation of <term id="T5" lex="nuclear_factor-kappaB" sem="Protein_complex">nuclear factor-kappaB</term> and <term id="T6" lex="transcriptional_regulation" sem="Other">transcriptional regulation</term> of <term id="T7" lex="endothelial_cell_adhesion_molecule" sem="Protein_family_or_group">endothelial cell adhesion molecules</term>.</sentence>
<event KT="Other" id="E3">
<type class="Positive_regulation"/>
<theme idref="T5"/>
<clue>Previous studies have implicated a role for intracellular thiols in the <clueType>activation</clueType> <linkTheme>of</linkTheme> nuclear factor-kappaB and transcriptional regulation of endothelial cell adhesion molecules.</clue>
</event>
<event KT="Other" id="E4">
<type class="Regulation"/>
<theme idref="T7"/>
<clue>Previous studies have implicated a role for intracellular thiols in the activation of nuclear factor-kappaB and transcriptional <clueType>regulation</clueType> <linkTheme>of</linkTheme> endothelial cell adhesion molecules.</clue>
</event>
<event CL="L2" KT="Analysis" Source="Other" id="E5">
<type class="Positive_regulation"/>
<theme idref="E3"/>
<cause idref="T4"/>
<clue><clueSource>Previous studies</clueSource> have <clueKT><clueCL>implicated</clueCL></clueKT> a <clueType>role</clueType> <linkCause>for</linkCause> intracellular thiols <linkTheme>in</linkTheme> the activation of nuclear factor-kappaB and transcriptional regulation of endothelial cell adhesion molecules.</clue>
</event>
<event CL="L2" KT="Analysis" Source="Other" id="E6">
<type class="Positive_regulation"/>
<theme idref="E4"/>
<cause idref="T4"/>
<clue><clueSource>Previous studies</clueSource> have <clueKT><clueCL>implicated</clueCL></clueKT> a <clueType>role</clueType> <linkCause>for</linkCause> intracellular thiols <linkTheme>in</linkTheme> the activation of nuclear factor-kappaB and transcriptional regulation of endothelial cell adhesion molecules.</clue>
</event>
<sentence id="S3">This study was designed to determine whether changes in <term id="T8" lex="endothelial_cell_glutathione" sem="Peptide"><term id="T1" sem="Cell_natural">endothelial cell</term> glutathione</term> (<term id="T10" lex="GSH" sem="Peptide">GSH</term>) or <term id="T11" lex="oxidized_glutathione" sem="Peptide">oxidized glutathione</term> (<term id="T13" lex="GSSG" sem="Peptide">GSSG</term>) can alter <term id="T14" lex="neutrophil_adhesivity" sem="Other"><term id="A3" sem="Cell_natural">neutrophil</term> adhesivity</term> and to define the molecular mechanism that underlies this <term id="T16" lex="GSSG" sem="Peptide">GSSG</term>/<term id="T18" lex="GSH" sem="Peptide">GSH</term>-induced <term id="A4" sem="Other">adhesion response</term>.</sentence>
<event KT="Other" id="E7">
<type class="Cell_adhesion"/>
<theme idref="A3"/>
<clue>This study was designed to determine whether changes in endothelial cell glutathione (GSH) or oxidized glutathione (GSSG) can alter neutrophil <clueType>adhesivity</clueType> and to define the molecular mechanism that underlies this GSSG/GSH-induced adhesion response.</clue>
</event>
<event KT="Other" id="E8">
<type class="Regulation"/>
<theme idref="T10"/>
<clue>This study was designed to determine whether <clueType>changes</clueType> <linkTheme>in</linkTheme> <clueLoc>endothelial cell</clueLoc> glutathione (GSH) or oxidized glutathione (GSSG) can alter neutrophil adhesivity and to define the molecular mechanism that underlies this GSSG/GSH-induced adhesion response.</clue>
</event>
<event KT="Other" id="E9">
<type class="Regulation"/>
<theme idref="T13"/>
<clue>This study was designed to determine whether <clueType>changes</clueType> <linkTheme>in</linkTheme> <clueLoc>endothelial cell</clueLoc> glutathione (GSH) or oxidized glutathione (GSSG) can alter neutrophil adhesivity and to define the molecular mechanism that underlies this GSSG/GSH-induced adhesion response.</clue>
</event>
<event KT="Investigation" id="E10" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E7"/>
<cause idref="E8"/>
<clue>This study was designed <clueKT>to determine</clueKT> whether changes in endothelial cell glutathione (GSH) or oxidized glutathione (GSSG) can <clueType>alter</clueType> neutrophil adhesivity and to define the molecular mechanism that underlies this GSSG/GSH-induced adhesion response.</clue>
</event>
<event KT="Other" id="E11">
<type class="Positive_regulation"/>
<theme idref="A4"/>
<cause idref="T16"/>
<clue>This study was designed to determine whether changes in endothelial cell glutathione (GSH) or oxidized glutathione (GSSG) can alter neutrophil adhesivity and to define the molecular mechanism that underlies this GSSG/GSH-<clueType>induced</clueType> adhesion response.</clue>
<comment>NER T17 mod</comment></event>
<event KT="Other" id="E12">
<type class="Positive_regulation"/>
<theme idref="A4"/>
<cause idref="T18"/>
<clue>This study was designed to determine whether changes in endothelial cell glutathione (GSH) or oxidized glutathione (GSSG) can alter neutrophil adhesivity and to define the molecular mechanism that underlies this GSSG/GSH-<clueType>induced</clueType> adhesion response.</clue>
<comment>NER T17 mod</comment></event>
<sentence id="S4">Treatment of <term id="T19" lex="human_umbilical_vein_endothelial_cell_(HUVEC)_monolayer" sem="Cell_cultured"><term id="T20" lex="human_umbilical_vein_endothelial_cell" sem="Cell_cultured">human umbilical vein endothelial cell</term> (<term id="T21" lex="HUVEC" sem="Cell_cultured">HUVEC</term>) monolayers</term> for 6 hours with 0.2 mmol/L <term id="A5" sem="Organic_compound_other">diamide</term> and 1 mmol/L <term id="T22" lex="buthionine_sulfoximine" sem="Organic_compound_other">buthionine sulfoximine</term> (<term id="T23" lex="BSO" sem="Organic_compound_other">BSO</term>) decreased <term id="T25" lex="GSH" sem="Peptide">GSH</term> levels and increased the <term id="A6" sem="Other">ratio of <term id="T26" lex="GSSG" sem="Peptide">GSSG</term> to <term id="T27" lex="GSH" sem="Peptide">GSH</term></term> without <term id="T28" lex="cell_toxicity" sem="Other">cell toxicity</term>.</sentence>
<event KT="Method" id="E13">
<type class="Artificial_process"/>
<theme idref="T21"/>
<theme idref="A5"/>
<theme idref="T23"/>
<clue><clueType>Treatment</clueType> <linkTheme>of</linkTheme> human umbilical vein endothelial cell (HUVEC) monolayers <clueTime>for 6 hours</clueTime> <linkTheme>with</linkTheme> 0.2 mmol/L diamide and 1 mmol/L buthionine sulfoximine (BSO) decreased GSH levels and increased the ratio of GSSG to GSH without cell toxicity.</clue>
<comment>TPS A6</comment></event>
<event id="E14">
<type class="Negative_regulation"/>
<theme idref="T25"/>
<cause idref="E13"/>
<clue>Treatment of human umbilical vein endothelial cell (HUVEC) monolayers for 6 hours with 0.2 mmol/L diamide and 1 mmol/L buthionine sulfoximine (BSO) <clueType>decreased</clueType> GSH levels and increased the ratio of GSSG to GSH without cell toxicity.</clue>
</event>
<event id="E15">
<type class="Positive_regulation"/>
<theme idref="A6"/>
<cause idref="E13"/>
<clue>Treatment of human umbilical vein endothelial cell (HUVEC) monolayers for 6 hours with 0.2 mmol/L diamide and 1 mmol/L buthionine sulfoximine (BSO) decreased GSH levels and <clueType>increased</clueType> the ratio of GSSG to GSH without cell toxicity.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E16">
<type class="Correlation"/>
<theme idref="T28"/>
<theme idref="E14"/>
<clue>Treatment of human umbilical vein endothelial cell (HUVEC) monolayers for 6 hours with 0.2 mmol/L diamide and 1 mmol/L buthionine sulfoximine (BSO) decreased GSH levels and increased the ratio of GSSG to GSH <clueType><cluePolarity>without</cluePolarity></clueType> cell toxicity.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E17">
<type class="Correlation"/>
<theme idref="T28"/>
<theme idref="E15"/>
<clue>Treatment of human umbilical vein endothelial cell (HUVEC) monolayers for 6 hours with 0.2 mmol/L diamide and 1 mmol/L buthionine sulfoximine (BSO) decreased GSH levels and increased the ratio of GSSG to GSH <clueType><cluePolarity>without</cluePolarity></clueType> cell toxicity.</clue>
</event>
<sentence id="S5">These redox changes are similar to those observed with <term id="T29" lex="anoxia/reoxygenation" sem="Other">anoxia/reoxygenation</term>.</sentence>
<sentence id="S6"><term id="A7" sem="Organic_compound_other">Diamide</term> plus <term id="T30" lex="BSO" sem="Organic_compound_other">BSO</term>-induced <term id="T31" lex="thiol/disulfide_imbalance" sem="Other"><term id="A8" sem="Organic_compound_other">thiol</term>/<term id="A9" sem="Inorganic_compound">disulfide</term> imbalance</term> was associated with a biphasic increase in <term id="T32" lex="neutrophil_adhesion" sem="Other"><term id="T33" lex="neutrophil" sem="Cell_natural">neutrophil</term> adhesion</term> to <term id="T34" lex="HUVEC" sem="Cell_cultured">HUVECs</term> with peak responses observed at 15 minutes (phase 1) and 240 minutes (phase 2).</sentence>
<event KT="Other" id="E18">
<type class="Positive_regulation"/>
<theme idref="T31"/>
<cause idref="A7"/>
<cause idref="T30"/>
<clue>Diamide plus BSO-<clueType>induced</clueType> thiol/disulfide imbalance was associated with a biphasic increase in neutrophil adhesion to HUVECs with peak responses observed at 15 minutes (phase 1) and 240 minutes (phase 2).</clue>
</event>
<event KT="Other" id="E19">
<type class="Cell_adhesion"/>
<theme idref="T33"/>
<theme idref="T34"/>
<clue>Diamide plus BSO-induced thiol/disulfide imbalance was associated with a biphasic increase in neutrophil <clueType>adhesion</clueType> <linkTheme>to</linkTheme> HUVECs with peak responses observed at 15 minutes (phase 1) and 240 minutes (phase 2).</clue>
</event>
<event KT="Other" id="E20">
<type class="Positive_regulation"/>
<theme idref="E19"/>
<clue>Diamide plus BSO-induced thiol/disulfide imbalance was associated with a biphasic <clueType>increase</clueType> <linkTheme>in</linkTheme> neutrophil adhesion to HUVECs with peak responses observed at 15 minutes (phase 1) and 240 minutes (phase 2).</clue>
</event>
<event KT="Analysis" id="E21">
<type class="Correlation"/>
<theme idref="E18"/>
<theme idref="E20"/>
<clue>Diamide plus BSO-induced thiol/disulfide imbalance was <clueType><clueKT>associated</clueKT></clueType> <linkTheme>with</linkTheme> a biphasic increase in neutrophil adhesion to HUVECs with peak responses observed at 15 minutes (phase 1) and 240 minutes (phase 2).</clue>
</event>
<sentence id="S7"><term id="T35" lex="N-Acetylcysteine_treatment" sem="Other"><term id="T36" lex="N-Acetylcysteine" sem="Amino_acid_monomer">N-Acetylcysteine</term> treatment</term> attenuated <term id="T37" lex="neutrophil_adhesion" sem="Other"><term id="T38" lex="neutrophil" sem="Cell_natural">neutrophil</term> adhesion</term> in both phases, which indicated a role for <term id="T39" lex="GSH" sem="Peptide">GSH</term> in the <term id="T40" lex="adhesion_response" sem="Other">adhesion responses</term>.</sentence>
<event id="E22">
<type class="Cell_adhesion"/>
<theme idref="T38"/>
<clue>N-Acetylcysteine treatment attenuated neutrophil <clueType>adhesion</clueType> in both phases, which indicated a role for GSH in the adhesion responses.</clue>
</event>
<event id="E23">
<type class="Negative_regulation"/>
<theme idref="E22"/>
<cause idref="T36"/>
<clue>N-Acetylcysteine treatment <clueType>attenuated</clueType> neutrophil adhesion in both phases, which indicated a role for GSH in the adhesion responses.</clue>
</event>
<event CL="L2" KT="Analysis" id="E24">
<type class="Regulation"/>
<theme idref="T40"/>
<cause idref="T39"/>
<clue>N-Acetylcysteine treatment attenuated neutrophil adhesion in both phases, which <clueKT><clueCL>indicated</clueCL></clueKT> a <clueType>role</clueType> <linkCause>for</linkCause> GSH <linkTheme>in</linkTheme> the adhesion responses.</clue>
</event>
<sentence id="S8">Interestingly, <term id="T41" lex="phase_1_adhesion" sem="Other">phase 1 adhesion</term> was inversely correlated with <term id="T43" lex="GSH" sem="Peptide">GSH</term> levels but not with the <term id="T45" lex="GSH_ratio" sem="Other"><term id="T44" lex="GSSG" sem="Peptide">GSSG</term>/<term id="T46" lex="GSH" sem="Peptide">GSH</term> ratio</term>, whereas phase 2 <term id="T47" lex="neutrophil_adhesion" sem="Other"><term id="T48" lex="neutrophil" sem="Cell_natural">neutrophil</term> adhesion</term> was positively correlated with <term id="A10" sem="Other"><term id="T49" lex="GSSG" sem="Peptide">GSSG</term>/<term id="T50" lex="GSH" sem="Peptide">GSH</term> ratio</term> but not with <term id="T52" lex="GSH" sem="Peptide">GSH</term> levels.</sentence>
<event KT="Analysis" id="E25">
<type class="Negative_regulation"/>
<theme idref="E22"/>
<cause idref="T43"/>
<clue>Interestingly, phase 1 <corefTheme>adhesion</corefTheme> was <clueType>inversely <clueKT>correlated</clueKT></clueType> <linkTheme>with</linkTheme> GSH levels but not with the GSSG/GSH ratio, whereas phase 2 neutrophil adhesion was positively correlated with GSSG/GSH ratio but not with GSH levels.</clue>
</event>
<event KT="Analysis" Polarity="Negative" assertion="non-exist" id="E26">
<type class="Negative_regulation"/>
<theme idref="E22"/>
<cause idref="T45"/>
<clue>Interestingly, phase 1 <corefTheme>adhesion</corefTheme> was <clueType>inversely <clueKT>correlated</clueKT></clueType> with GSH levels but <cluePolarity>not</cluePolarity> <linkTheme>with</linkTheme> the GSSG/GSH ratio, whereas phase 2 neutrophil adhesion was positively correlated with GSSG/GSH ratio but not with GSH levels.</clue>
</event>
<event KT="Other" id="E27">
<type class="Cell_adhesion"/>
<theme idref="T48"/>
<clue>Interestingly, phase 1 adhesion was inversely correlated with GSH levels but not with the GSSG/GSH ratio, whereas phase 2 neutrophil <clueType>adhesion</clueType> was positively correlated with GSSG/GSH ratio but not with GSH levels.</clue>
</event>
<event KT="Analysis" id="E28">
<type class="Positive_regulation"/>
<theme idref="E27"/>
<cause idref="A10"/>
<clue>Interestingly, phase 1 adhesion was inversely correlated with GSH levels but not with the GSSG/GSH ratio, whereas phase 2 neutrophil adhesion was <clueType>positively <clueKT>correlated</clueKT></clueType> <linkTheme>with</linkTheme> GSSG/GSH ratio but not with GSH levels.</clue>
</event>
<event KT="Analysis" Polarity="Negative" assertion="non-exist" id="E29">
<type class="Positive_regulation"/>
<theme idref="E27"/>
<cause idref="T52"/>
<clue>Interestingly, phase 1 adhesion was inversely correlated with GSH levels but not with the GSSG/GSH ratio, whereas phase 2 neutrophil adhesion was <clueType>positively <clueKT>correlated</clueKT></clueType> with GSSG/GSH ratio but <cluePolarity>not</cluePolarity> <linkTheme>with</linkTheme> GSH levels.</clue>
</event>
<sentence id="S9"><term id="T53" lex="intercellular_adhesion_molecule-1" sem="Protein_family_or_group">Intercellular adhesion molecule-1</term> and <term id="T54" lex="P-selectin-specific_monoclonal_antibody" sem="Protein_family_or_group"><term id="A11" sem="Protein_molecule">P-selectin</term>-specific monoclonal antibodies</term> attenuated the increased <term id="T55" lex="neutrophil_adhesion" sem="Other"><term id="T56" lex="neutrophil" sem="Cell_natural">neutrophil</term> adhesion</term> during both phases, whereas an <term id="T57" lex="anti-E-selectin_monoclonal_antibody" sem="Protein_family_or_group">anti-<term id="A12" sem="Protein_molecule">E-selectin</term> <term id="T58" lex="monoclonal_antibody" sem="Protein_family_or_group">monoclonal antibody</term></term> also attenuated the phase 2 response.</sentence>
<event id="E30">
<type class="Cell_adhesion"/>
<theme idref="T56"/>
<clue>Intercellular adhesion molecule-1 and P-selectin-specific monoclonal antibodies attenuated the increased neutrophil <clueType>adhesion</clueType> during both phases, whereas an anti-E-selectin monoclonal antibody also attenuated the phase 2 response.</clue>
</event>
<event id="E31">
<type class="Positive_regulation"/>
<theme idref="E30"/>
<clue>Intercellular adhesion molecule-1 and P-selectin-specific monoclonal antibodies attenuated the <clueType>increased</clueType> neutrophil adhesion during both phases, whereas an anti-E-selectin monoclonal antibody also attenuated the phase 2 response.</clue>
</event>
<event id="E32">
<type class="Negative_regulation"/>
<theme idref="E31"/>
<cause idref="T53"/>
<clue>Intercellular adhesion molecule-1 and P-selectin-specific monoclonal antibodies <clueType>attenuated</clueType> the increased neutrophil adhesion <clueTime>during both phases</clueTime>, whereas an anti-E-selectin monoclonal antibody also attenuated the phase 2 response.</clue>
</event>
<event id="E33">
<type class="Negative_regulation"/>
<theme idref="E31"/>
<cause idref="T54"/>
<clue>Intercellular adhesion molecule-1 and P-selectin-specific monoclonal antibodies <clueType>attenuated</clueType> the increased neutrophil adhesion <clueTime>during both phases</clueTime>, whereas an anti-E-selectin monoclonal antibody also attenuated the phase 2 response.</clue>
</event>
<event id="E34">
<type class="Negative_regulation"/>
<theme idref="E31"/>
<cause idref="T57"/>
<clue>Intercellular adhesion molecule-1 and P-selectin-specific monoclonal antibodies attenuated the increased neutrophil adhesion during both phases, whereas an anti-E-selectin monoclonal antibody also <clueType>attenuated</clueType> the phase 2 <corefTheme>response</corefTheme>.</clue>
</event>
<sentence id="S10">Pretreatment with <term id="T59" lex="actinomycin_D" sem="Organic_compound_other">actinomycin D</term> and <term id="T60" lex="cycloheximide" sem="Organic_compound_other">cycloheximide</term> or with <term id="A13" sem="Polynucleotide">competing <term id="T61" lex="ds-oligonucleotide" sem="Polynucleotide">ds-oligonucleotides</term> that contained</term> <term id="A21" sem="Polynucleotide"><term id="T62" lex="nuclear_factor-kappaB" sem="Protein_complex">nuclear factor-kappaB</term></term> or <term id="A22" sem="Polynucleotide"><term id="T63" lex="activator_protein-1" sem="Protein_molecule">activator protein-1</term></term> <term id="A23" sem="Polynucleotide">cognate DNA sequences</term> significantly attenuated the <term id="T64" lex="phase_2_response" sem="Other">phase 2 response</term>, which implicated a role for <term id="T65" lex="de_novo_protein_synthesis" sem="Other">de novo protein synthesis</term>.</sentence>
<event KT="Method" id="E35">
<type class="Artificial_process"/>
<theme idref="T59"/>
<theme idref="T60"/>
<clue><clueType>Pretreatment</clueType> <linkTheme>with</linkTheme> actinomycin D and cycloheximide or with competing ds-oligonucleotides that contained nuclear factor-kappaB or activator protein-1 cognate DNA sequences significantly attenuated the phase 2 response, which implicated a role for de novo protein synthesis.</clue>
<comment>TPS A13</comment></event>
<event KT="Method" id="E36">
<type class="Artificial_process"/>
<theme idref="A13" idref1="A21" idref2="A23"/>
<clue><clueType>Pretreatment</clueType> with actinomycin D and cycloheximide or <linkTheme>with</linkTheme> competing ds-oligonucleotides that contained nuclear factor-kappaB or activator protein-1 cognate DNA sequences significantly attenuated the phase 2 response, which implicated a role for de novo protein synthesis.</clue>
</event>
<event KT="Method" id="E55">
<type class="Artificial_process"/>
<theme idref="A13" idref1="A22" idref2="A23"/>
<clue><clueType>Pretreatment</clueType> with actinomycin D and cycloheximide or <linkTheme>with</linkTheme> competing ds-oligonucleotides that contained nuclear factor-kappaB or activator protein-1 cognate DNA sequences significantly attenuated the phase 2 response, which implicated a role for de novo protein synthesis.</clue>
</event>
<event Manner="High" id="E37">
<type class="Negative_regulation"/>
<theme idref="E31"/>
<cause idref="E35"/>
<clue>Pretreatment with actinomycin D and cycloheximide or with competing ds-oligonucleotides that contained nuclear factor-kappaB or activator protein-1 cognate DNA sequences <clueManner>significantly</clueManner> <clueType>attenuated</clueType> the phase 2 <corefTheme>response</corefTheme>, which implicated a role for de novo protein synthesis.</clue>
</event>
<event CL="L2" KT="Analysis" id="E38">
<type class="Correlation"/>
<theme idref="E31"/>
<theme idref="T65"/>
<clue>Pretreatment with actinomycin D and cycloheximide or with competing ds-oligonucleotides that contained nuclear factor-kappaB or activator protein-1 cognate DNA sequences significantly attenuated the phase 2 response, which <clueKT><clueCL>implicated</clueCL></clueKT> a <clueType>role</clueType> <linkCause>for</linkCause> de novo protein synthesis.</clue>
</event>
<sentence id="S11">Surface expression of <term id="T66" lex="intercellular_adhesion_molecule-1" sem="Protein_molecule">intercellular adhesion molecule-1</term>, <term id="T67" lex="P-selectin" sem="Protein_molecule">P-selectin</term>, and <term id="T68" lex="E-selectin" sem="Protein_molecule">E-selectin</term> on <term id="T69" lex="HUVEC" sem="Cell_cultured">HUVECs</term> correlated with the <cons id="T70" lex="(AND phase_1_neutrophil_adhesion_response phase_2_neutrophil_adhesion_response)" sem="(AND Other Other)"><frag id="F1">phase</frag> <frag id="F2">1</frag> and <frag id="F3">2</frag> <frag id="F4"><term id="T71" lex="neutrophil" sem="Cell_natural">neutrophil</term> adhesion responses</frag></cons>.</sentence>
<event KT="Other" id="E39">
<type class="Gene_expression"/>
<theme idref="T66"/>
<clue><clueLoc>Surface</clueLoc> <clueType>expression</clueType> <linkTheme>of</linkTheme> intercellular adhesion molecule-1, P-selectin, and E-selectin <clueLoc>on HUVECs</clueLoc> correlated with the phase 1 and 2 neutrophil adhesion responses.</clue>
</event>
<event KT="Other" id="E40">
<type class="Gene_expression"/>
<theme idref="T67"/>
<clue><clueLoc>Surface</clueLoc> <clueType>expression</clueType> <linkTheme>of</linkTheme> intercellular adhesion molecule-1, P-selectin, and E-selectin <clueLoc>on HUVECs</clueLoc> correlated with the phase 1 and 2 neutrophil adhesion responses.</clue>
</event>
<event KT="Other" id="E41">
<type class="Gene_expression"/>
<theme idref="T68"/>
<clue><clueLoc>Surface</clueLoc> <clueType>expression</clueType> <linkTheme>of</linkTheme> intercellular adhesion molecule-1, P-selectin, and E-selectin <clueLoc>on HUVECs</clueLoc> correlated with the phase 1 and 2 neutrophil adhesion responses.</clue>
</event>
<event KT="Other" id="E42">
<type class="Cell_adhesion"/>
<theme idref="T71"/>
<clue>Surface expression of intercellular adhesion molecule-1, P-selectin, and E-selectin on HUVECs correlated with the phase 1 and 2 neutrophil <clueType>adhesion</clueType> responses.</clue>
</event>
<event KT="Analysis" id="E43">
<type class="Correlation"/>
<theme idref="E39"/>
<theme idref="E42"/>
<clue>Surface expression of intercellular adhesion molecule-1, P-selectin, and E-selectin on HUVECs <clueType><clueKT>correlated</clueKT></clueType> <linkTheme>with</linkTheme> the phase 1 and 2 neutrophil adhesion responses.</clue>
</event>
<event KT="Analysis" id="E44">
<type class="Correlation"/>
<theme idref="E40"/>
<theme idref="E42"/>
<clue>Surface expression of intercellular adhesion molecule-1, P-selectin, and E-selectin on HUVECs <clueType><clueKT>correlated</clueKT></clueType> <linkTheme>with</linkTheme> the phase 1 and 2 neutrophil adhesion responses.</clue>
</event>
<event KT="Analysis" id="E45">
<type class="Correlation"/>
<theme idref="E41"/>
<theme idref="E42"/>
<clue>Surface expression of intercellular adhesion molecule-1, P-selectin, and E-selectin on HUVECs <clueType><clueKT>correlated</clueKT></clueType> <linkTheme>with</linkTheme> the phase 1 and 2 neutrophil adhesion responses.</clue>
</event>
<sentence id="S12">This study demonstrates that changes in <term id="T72" lex="endothelial_cell_GSSG/GSH" sem="Peptide">endothelial cell <term id="T73" lex="GSSG" sem="Peptide">GSSG</term><term id="T74" lex="GSH" sem="Peptide">/GSH</term></term> cause transcription-independent and <term id="T12" sem="Other">transcription</term>-dependent <term id="T9" sem="Other"><term id="T15" sem="Cell_component">surface</term> expression</term> of different <term id="T76" lex="endothelial_cell_adhesion_molecule" sem="Protein_family_or_group">endothelial cell adhesion molecules</term>, which leads to a <term id="T77" lex="2-phase_neutrophil-endothelial_adhesion_response" sem="Other">2-phase <term id="T78" lex="neutrophil" sem="Cell_natural">neutrophil</term>-<term id="A14" sem="Cell_natural">endothelial</term> adhesion response</term>.</sentence>
<event KT="Other" id="E46">
<type class="Gene_expression"/>
<theme idref="T76"/>
<clue>This study demonstrates that changes in endothelial cell GSSG/GSH cause transcription-independent and transcription-dependent <clueLoc>surface</clueLoc> <clueType>expression</clueType> <linkTheme>of</linkTheme> different endothelial cell adhesion molecules, which leads to a 2-phase neutrophil-endothelial adhesion response.</clue>
</event>
<event KT="Other" id="E47">
<type class="Regulation"/>
<theme idref="T45"/>
<clue>This study demonstrates that <clueType>changes</clueType> <linkTheme>in</linkTheme> <clueLoc>endothelial cell</clueLoc> <corefTheme>GSSG/GSH</corefTheme> cause transcription-independent and transcription-dependent surface expression of different endothelial cell adhesion molecules, which leads to a 2-phase neutrophil-endothelial adhesion response.</clue>
</event>
<event KT="Analysis" id="E48">
<type class="Positive_regulation"/>
<theme idref="E46"/>
<cause idref="E47"/>
<clue>This study <clueKT>demonstrates</clueKT> that changes in endothelial cell GSSG/GSH <clueType>cause</clueType> transcription-independent and transcription-dependent surface expression of different endothelial cell adhesion molecules, which leads to a 2-phase neutrophil-endothelial adhesion response.</clue>
</event>
<event KT="Other" id="E49">
<type class="Cell_adhesion"/>
<theme idref="T78"/>
<theme idref="A14"/>
<clue>This study demonstrates that changes in endothelial cell GSSG/GSH cause transcription-independent and transcription-dependent surface expression of different endothelial cell adhesion molecules, which leads to a 2-phase neutrophil-endothelial <clueType>adhesion</clueType> response.</clue>
</event>
<event KT="Other" id="E50">
<type class="Positive_regulation"/>
<theme idref="E49"/>
<cause idref="E48"/>
<clue>This study demonstrates that changes in endothelial cell GSSG/GSH cause transcription-independent and transcription-dependent surface expression of different endothelial cell adhesion molecules, which <clueType>leads</clueType> <linkTheme>to</linkTheme> a 2-phase neutrophil-endothelial adhesion response.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
